Kiker Wealth Management’s Editas Medicine EDIT Stock Holding History

Kiker Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50	Closed	-$110	–	349
2025 Q2	$110	Buy	+50	New	+$82	﹤0.01%	595

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kiker Wealth Management's EDIT Position: Q3 2025 in Review

Kiker Wealth Management sold out of Editas Medicine (EDIT) in Q3 2025, closing a stake of 50 shares — an estimated $110 sold.

Kiker Wealth Management first reported a position in EDIT in Q2 2025 and held it in 1 quarter. The position peaked at $110 in Q2 2025. 193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

Kiker Wealth Management reported no remaining Editas Medicine position as of Q3 2025 after selling out during the quarter.
Kiker Wealth Management sold 50 Editas Medicine shares in Q3 2025, an estimated $110.
Kiker Wealth Management first reported a position in Editas Medicine in Q2 2025 and held it in 1 quarter.
Kiker Wealth Management's Editas Medicine position peaked at $110 in Q2 2025.
193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on Kiker Wealth Management's 13F filing for Q3 2025, filed 27 Oct 2025.